Compass Oncology the Northwest Cancer Specialists

19260 Southwest 65th Avenue
Tualatin, Oregon 97062

We've found

1 trials

at this facility

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Tualatin, OR

Use our guide to learn which trials are right for you!